In agreeing to settle the largest case of health care fraud in U.S. history, GlaxoSmithKline pled guilty today to marketing Paxil for teens and children and to advertising Wellbutrin for weight loss and sexual dysfuntion. Glaxo will pay $1 billion in criminal fines and $2 billion in civil fines for activities such as distributing a misleading journal article and providing kickbacks to doctors. “Today’s historic settlement is a major milestone in our efforts to stamp out health care fraud,” said the deputy secretary of health and human services in a statement. Article → Related Item: GlaxoSmithKline settles healthcare fraud case for $3 billion Glaxo Agrees to Pay $3 Billion in Fraud Settlement
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.